News Medicare to fund Abbott's needle-free diabetes monitor Abbott's new glucose monitoring device could be used by millions of diabetes patients in the US after government-funded health schemes agreed to pay for it.
News BioMarin snaps up Alesta's lead asset for $275M BioMarin will acquire Alesta's experimental therapy for rare bone disease hypophosphatasia for up to $490 million.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.